People with type 2 diabetes on a high-fat, low-carbohydrate diet may have a better chance of reversing their diabetes than ...
The first cohort of the TEADCO trial evaluates ODM-212 in combination with ipilimumab and nivolumab as a first-line treatment ...
Calidi Biotherapeutics, Inc. (NYSE American: CLDI) ('Calidi” or the 'Company”), a biotechnology company pioneering the development of targeted genetic medicines, presented new data at the American ...
Fuel cell technologies are playing an increasingly important role in the energy field. Over the past two years, researchers publishing in ENGINEERING Energy (formerly Frontiers in Energy) have ...
Sen. Mark Warner's daughter Madison has died following a decades-long battle with juvenile diabetes. Here's what to know ...
Low dose resulted in 89% median disabling seizure reduction in participants with MTS during the 7-12-month primary efficacy ...
Obsidian Therapeutics, Inc., a clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor-infiltrating lymphocyte (TIL) cell therapies, today ...
Kyverna Therapeutics reported robust early Phase 2 miv-cel data in gMG, showing 100% response rates and deep, durable ...
UCSF research led to the first type 1 diabetes immunotherapy. Now, scientists are using stem cells and Tregs to find a ...
Mega Crit's roguelike sequel is just as challenging as the first, so we've put together a guide to the best Slay the Spire 2 ...
A single-arm study hints at an uptick in pathologic complete responses when a CD39 blocker is added to perioperative ...
After six weeks in the hospital, 23‑year‑old Daniel Cressy leaves with hope for a functional cure and a future where he can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results